<scp>ZNF521</scp> / <scp>EBF1</scp> axis regulates <scp>AKR1B1</scp> to promote the proliferation, migration, and invasion of gastric cancer cells-Reference-Cited by-同舟云学术

ZNF521 / EBF1 axis regulates AKR1B1 to promote the proliferation, migration, and invasion of gastric cancer cells

Published:2022-11-17 Issue:3 Volume:39 Page:244-253
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung J of Med Scie

Author:

Cheng Yu¹,Ni Yi‐Jiang¹,Tang Li‐Ming¹^ORCID

Affiliation:

1. Department of Gastrointestinal Surgery Changzhou No. 2 People's Hospital (Affiliated Hospital of Nanjing Medical University) Changzhou Jiangsu People's Republic of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12624

Reference26 articles.

1. Global Incidence and Mortality of Gastric Cancer, 1980-2018

2. Gastric carcinoma in China: Current status and future perspectives (Review)

3. Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version)

4. Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices

5. Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ZNF521 promotes acute myeloid leukemogenesis by suppressing the expression and acetylation of SMC3;Heliyon;2024-09

2. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer;Cancer Management and Research;2024-07

3. Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology;Heliyon;2024-03

4. Lipid Metabolism-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Advanced Gastric Cancer;Gastroenterology Research and Practice;2024-02-26

5. Aldo-keto reductases: Role in cancer development and theranostics;Oncology Research;2024